Willingness To Pay To Eliminate the Risk of Restenosis Following Percutaneous Coronary Intervention A Contingent Valuation

被引:2
|
作者
Guertin, Jason R. [1 ,2 ]
Liu, Aihua [3 ,4 ]
Abrahamowicz, Michal [3 ,4 ]
Cohen, David J. [6 ]
Ismail, Salma [2 ]
LeLorier, Jacques [1 ,2 ]
Brophy, James M. [3 ,4 ,5 ]
Rinfret, Stephane [2 ,7 ]
机构
[1] Univ Montreal, Montreal, PQ H3C 3J7, Canada
[2] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada
[3] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada
[5] McGill Univ, Ctr Hlth, Div Cardiol, Montreal, PQ, Canada
[6] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[7] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2011年 / 4卷 / 01期
关键词
restenosis; stents; cost-benefit analysis; SIROLIMUS-ELUTING STENTS; HIERARCHICAL BAYESIAN METAANALYSIS; HEALTH-CARE; COST-EFFECTIVENESS; ECONOMIC-EVALUATION; ANGIOPLASTY; TRIALS;
D O I
10.1161/CIRCOUTCOMES.109.915421
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Percutaneous coronary intervention (PCI) remains limited by the risk of restenosis. Patients' perceptions of the health benefits and value of avoiding restenosis are incompletely known. Methods and Results-We used a contingent valuation approach to assess the willingness to pay (WTP) for a hypothetical treatment that eliminates the risk of restenosis among 270 PCI patients. Patients were provided with a scenario describing a baseline 10% or 20% probability of restenosis in the year following the procedure, which could lead to repeat PCI or, more rarely, bypass surgery, without any increase in mortality. Six different "take it or leave it" bids ($500, $1000, $1500, $2000, $2500, and $3000) and both risk levels were randomly assigned. Multiple logistic regression was used to identify independent predictors of a positive response to the WTP question. Using nonparametric methods, the median WTP to eliminate the risk of restenosis was estimated at $2802. As expected, higher income was independently associated with a higher probability of a positive response to the WTP question (odds ratio, 2.81; 95% CI, 1.32 to 5.97). Bids also were independently associated with the probability of being willing to pay, and this association followed a quadratic effect. Below $1500, bid had little impact on patient answers. However, as prices increased, the probability of being willing to pay started to decrease sharply. Conclusion-The potential to eliminate the risk of restenosis, a benign complication, would have substantial value for patients undergoing PCI. (Circ Cardiovasc Qual Outcomes. 2011;4:46-52.)
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [31] Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention
    Monraats, Pascalle S.
    Fang, Yue
    Pons, Douwe
    Pires, Nuno M. M.
    Pols, Huibert A. P.
    Zwinderman, Aeilko H.
    de Maat, Moniek P. M.
    Doevendans, Pieter A. F.
    deWinter, Robbert J.
    Tio, Rene A.
    Waltenberger, Johannes
    Frants, Rune R.
    Quax, Paul H. A.
    van der Laarse, Arnoud
    van der Wall, Ernst E.
    Uitterlinden, Andre G.
    Jukema, J. Wouter
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (03) : 243 - 251
  • [32] Willingness-to-pay for improvement of hypothetical health status in patients visiting the emergency department: A contingent valuation study
    Seyedin, Hesam
    Safari, Mehdi
    Parnian, Elaheh
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2020, 8 (01): : 66 - 69
  • [33] THE EARLY PHENOMENA OF RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    UEDA, M
    BECKER, AE
    FUJIMOTO, T
    TSUKADA, T
    EUROPEAN HEART JOURNAL, 1991, 12 (08) : 937 - 945
  • [34] Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysis
    Miao, Hai-Wei
    Gong, Hui
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2015, 16 (04) : 844 - 850
  • [35] Percutaneous coronary intervention risk scores
    De Candia, Gianfranco
    MINERVA CARDIOANGIOLOGICA, 2018, 66 (05): : 569 - 575
  • [36] Postprandial increase in plasma concentrations of remnant-like particles: An independent risk factor for restenosis after percutaneous coronary intervention
    Oi, K
    Shimokawa, H
    Hirakawa, Y
    Tashiro, H
    Nakaike, R
    Kozai, T
    Ohzono, K
    Yamamoto, K
    Koyanagi, S
    Okamatsu, S
    Tajimi, T
    Kikuchi, Y
    Takeshita, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (01) : 66 - 73
  • [37] Effects of rosuvastatin combined with probucol on restenosis after percutaneous coronary intervention
    Wei, Dajun
    Xu, Hongjie
    Gai, Xiaodong
    Jiang, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (04): : 3961 - 3967
  • [38] Endothelial dysfunction predicts clinical restenosis after percutaneous coronary intervention
    Munk, Peter Scott
    Butt, Noreen
    Larsen, Alf Inge
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2011, 45 (03) : 139 - 145
  • [39] Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention
    Alessandro Lupi
    Gioel Gabrio Secco
    Andrea Rognoni
    Lidia Rossi
    Maurizio Lazzero
    Federico Nardi
    Roberta Rolla
    Giorgio Bellomo
    Angelo Sante Bongo
    Carlo Di Mario
    Journal of Thrombosis and Thrombolysis, 2012, 33 : 308 - 317
  • [40] Impact of anemia on in-stent restenosis after percutaneous coronary intervention
    Hu, Huilin
    Wang, Shijun
    Tang, Guanmin
    Zhai, Changlin
    Shen, Liang
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)